Cargando…
Cutaneous mucormycosis following COVID-19 vaccination in a patient with bullous pemphigoid
Autores principales: | Shah, Kishan M., West, Cameron, Simpson, Jana, Rainwater, Yevgeniya B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233544/ https://www.ncbi.nlm.nih.gov/pubmed/34222572 http://dx.doi.org/10.1016/j.jdcr.2021.06.012 |
Ejemplares similares
-
Cutaneous Mucormycosis Following a Bullous Pemphigoid Flare in a Chronic Lymphocytic Leukemia Patient on Ibrutinib
por: Stein, Matthew K., et al.
Publicado: (2018) -
Bullous pemphigoid and COVID-19 vaccine()
por: Pérez-López, Israel, et al.
Publicado: (2021) -
Cutaneous Dermatophytosis Mimicking Bullous Pemphigoid or Typical Bullous Pemphigoid and Tinea Incognito?
por: Andrés, Tirado-Sánchez, et al.
Publicado: (2019) -
Bullous pemphigoid following COVID-19 vaccine: An autoimmune disorder
por: Aashish, et al.
Publicado: (2022) -
Cutaneous Cytomegalovirus Infection Presenting As Recalcitrant Bullous Pemphigoid Lesion
por: Baek, Gayun, et al.
Publicado: (2023)